/PRNewswire/ PRECISIONxtract, a Precision Value & Health team, announced the launch of OncoGenius, a new digital data and analytic-based solution that.
Precision for Medicine and Trialbee Partner to Advance Clinical Trials for Complex Therapies and Speed Shift Toward Precision MedicineAugust 05, 2021 09:00 AM Eastern Daylight TimeMALMO, Sweden & BETHESDA, Md. (BUSINESS WIRE) Clinical research organization Precision for Medicine and Trialbee, a.
Precision for Medicine and Trialbee Partner to Advance Clinical Trials for Complex Therapies and Speed Shift Toward Precision Medicine finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK, April 14, 2021 /PRNewswire/ PRECISIONvalue, a Precision Value & Health team, today announced the further strategic expansion of its Access Experience Team (AET), a specialized group of former access decision markers, with the addition of Christy Banach. Christy s deep oncology practice background bolsters Precison s ability to futher drive strategic and implementation support related to real-time experiences being managed at the point of patient care within oncology practices.
To address the dynamic market access landscape, Precision has assembled the AET, an industry-leading group of 25+ former market access decision makers. As day-to-day leaders in access decision-making roles, AET members have an intimate understanding of the evolving drug marketplace and strong ties to their current industry. From this nuanced understanding of how market access stakeholders measure value and the supporting evidence, the AET works across Precis
Precision Medicine Group Significantly Expands Cell And Gene Therapy Expertise With Acquisition Of Project Farma
News provided by
Share this article
Share this article
LEADING BIO-ENGINEERING AND MANUFACTURING SERVICES FIRM CATALYZES THE LAUNCH OF PRECISION S CELL AND GENE THERAPY OFFERING PRECISION ADVANCE ADDRESSING THE UNIQUE CHALLENGES OF CELL & GENE THERAPY INNOVATORS, FROM DEVELOPMENT THROUGH COMMERCIALIZATION
BETHESDA, Md., Jan. 14, 2021 /PRNewswire/ Precision Medicine Group ( PMG ) announced today it has acquired Project Farma, a patient-focused bioengineering services firm that supports life science innovators in the manufacturing and scale-up of advanced therapies. Project Farma provides Precision a market-leading expertise in the manufacturing of life-changing medicines, with a unique focus in the rapidly growing area of cell and gene therapy. The acquisition adds Project Farma s unique expertise to Precision s suite of end-to-end cell and gene therapy capabilit